Pharmaceutical Manufacturer Assertio Therapeutics, Inc. to Pay $3.6 Million to Resolve Allegations that It Violated the False Claims Act in Connection with Marketing its Fentanyl Product
Pharmaceutical Manufacturer Assertio Therapeutics, Inc. to Pay $3.6 Million to Resolve Allegations that It Violated the False Claims Act in Connection with Marketing its Fentanyl Product